Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.
Despite meaningful progress in HIV prevention, the HIV epidemic is far from over, with 31,000 new diagnoses in the U.S. each ...
Shingles Vaccination Linked to Vascular Benefits With Breakthrough Infections and in People With HIV
Several observational analyses suggest higher cardiovascular and dementia risks in those with and without HIV who get ...
The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...
A recently approved twice-yearly injection to prevent HIV may warrant a higher price, but thousands of dollars more? CVS Caremark’s chief medical officer calls on Gilead Sciences to lower the $28,000 ...
A study of an urban US population reports a sharp decline in dermatologic disease in people with newly diagnosed HIV and ...
HIV Alliance has received a $12,000 grant from the Cow Creek Umpqua Indian Foundation to support individuals experiencing ...
South Africa has welcomed a U.S. bridging plan worth $115 million to continue funding HIV treatment and prevention programs ...
Pricing issues have taken precedence as CVS Health’s (NYSE:CVS) pharmacy benefit manager, CVS Caremark, continues to hold off ...
It’s a Sunday night at DreamGirls Hair Salon in Culver City, but something’s different. The usual hum of blow dryers and ...
After tense negotiations, Gilead Sciences has agreed not to boost prices next year for HIV medicines that are sold to state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback